Cargando…

Vitiligo-like lesions in a patient treated with nivolumab for renal cell carcinoma

RATIONALE: The introduction of immune check-point inhibitors (ICIs) in the treatment of solid neoplasms is associated with the need to know and manage a new type of side effects that are commonly defined immune-mediated adverse events. Dermatologic immune-mediated adverse events are relatively commo...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lolli, Cristian, Medri, Matelda, Ricci, Michela, Schepisi, Giuseppe, Filograna, Alessia, De Giorgi, Ugo, Stanganelli, Ignazio
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Wolters Kluwer Health 2018
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6314787/ https://www.ncbi.nlm.nih.gov/pubmed/30593172 http://dx.doi.org/10.1097/MD.0000000000013810

Ejemplares similares

Cutaneous side effects and types of dermatological reactions in metastatic melanoma patients treated by immunotherapies or targeted therapies: A retrospective single center study
por: Gullo, Giulia, et al.
Publicado: (2022)

Vitamin D Deficiency in Testicular Cancer Survivors: A Systematic Review
por: Schepisi, Giuseppe, et al.
Publicado: (2021)

A Phase II Study of Everolimus Plus Oral Prednisone in Patients with Metastatic Renal Cell Cancer
por: Lolli, Cristian, et al.
Publicado: (2017)

The New Frontier of Immunotherapy: Chimeric Antigen Receptor T (CAR-T) Cell and Macrophage (CAR-M) Therapy against Breast Cancer
por: Schepisi, Giuseppe, et al.
Publicado: (2023)

The Interplay between Inflammation, Anti-Angiogenic Agents, and Immune Checkpoint Inhibitors: Perspectives for Renal Cell Cancer Treatment
por: Brighi, Nicole, et al.
Publicado: (2019)

Parental Use and Educational Campaigns on Sunbed Use Among Teenagers and Adolescents
por: Stanganelli, Ignazio, et al.
Publicado: (2016)

Is Pediatric Melanoma Really That Different from Adult Melanoma? A Multicenter Epidemiological, Clinical and Dermoscopic Study
por: De Giorgi, Vincenzo, et al.
Publicado: (2023)

Vitiligo-like Lesions and COVID-19: Case Report and Review of Vaccination- and Infection-Associated Vitiligo
por: Macca, Laura, et al.
Publicado: (2022)

Plasma AR Copy Number Changes and Outcome to Abiraterone and Enzalutamide
por: Gurioli, Giorgia, et al.
Publicado: (2020)

Baseline Plasma Tumor DNA (ctDNA) Correlates with PSA Kinetics in Metastatic Castration-Resistant Prostate Cancer (mCRPC) Treated with Abiraterone or Enzalutamide
por: Conteduca, Vincenza, et al.
Publicado: (2022)

Size Functions for the Morphological Analysis of Melanocytic Lesions
por: Ferri, Massimo, et al.
Publicado: (2010)

Cemiplimab-Induced Alopecia Areata
por: Piraccini, Bianca Maria, et al.
Publicado: (2023)

Nivolumab-associated vitiligo-like depigmentation in a patient with acute myeloid leukemia: A novel finding
por: Yin, Emily S., et al.
Publicado: (2017)

Lesion presenting with a “blue amber” pattern
por: Pagliarello, Calogero, et al.
Publicado: (2016)

Circulating AR copy number and outcome to enzalutamide in docetaxel-treated metastatic castration-resistant prostate cancer
por: Salvi, Samanta, et al.
Publicado: (2016)

Potential Application of Chimeric Antigen Receptor (CAR)-T Cell Therapy in Renal Cell Tumors
por: Schepisi, Giuseppe, et al.
Publicado: (2020)

Prognostic Role of Systemic Inflammatory Indexes in Germ Cell Tumors Treated With High-Dose Chemotherapy
por: Cursano, Maria Concetta, et al.
Publicado: (2020)

Immune checkpoint inhibitors and Chimeric Antigen Receptor (CAR)-T cell therapy: Potential treatment options against Testicular Germ Cell Tumors
por: Schepisi, Giuseppe, et al.
Publicado: (2023)

CAR-T cell therapy: a potential new strategy against prostate cancer
por: Schepisi, Giuseppe, et al.
Publicado: (2019)

Vitiligo Adverse Event Observed in a Patient With Durable Complete Response After Nivolumab for Metastatic Renal Cell Carcinoma
por: Billon, Emilien, et al.
Publicado: (2019)

Circulating tumor cell gene expression and plasma AR gene copy number as biomarkers for castration-resistant prostate cancer patients treated with cabazitaxel
por: Gurioli, Giorgia, et al.
Publicado: (2022)

Vitiligo and tumor response in a patient with amelanotic melanoma undergoing nivolumab treatment
por: Furune, Satoshi, et al.
Publicado: (2021)

Flare phenomenon in prostate cancer: recent evidence on new drugs and next generation imaging
por: Conteduca, Vincenza, et al.
Publicado: (2021)

Immunotherapy “Shock” with vitiligo due to nivolumab administration as third line therapy in lung adenocarcinoma
por: Zarogoulidis, Paul, et al.
Publicado: (2017)

Vitiligo in a patient undergoing nivolumab treatment for non–small cell lung cancer
por: Kosche, Cory, et al.
Publicado: (2018)

Correction to: Vitiligo and tumor response in a patient with amelanotic melanoma undergoing nivolumab treatment
por: Furune, Satoshi, et al.
Publicado: (2021)

Combining liquid biopsy and functional imaging analysis in metastatic castration‐resistant prostate cancer helps predict treatment outcome
por: Conteduca, Vincenza, et al.
Publicado: (2021)

Sodium Levels and Outcomes in Patients With Metastatic Renal Cell Carcinoma Receiving Nivolumab
por: Catalano, Martina, et al.
Publicado: (2023)

Imiquimod induced vitiligo‐like lesions—A consequence of modified melanocyte function
por: Yu, Haiyan, et al.
Publicado: (2021)

Immunotherapy and Its Development for Gynecological (Ovarian, Endometrial and Cervical) Tumors: From Immune Checkpoint Inhibitors to Chimeric Antigen Receptor (CAR)-T Cell Therapy
por: Schepisi, Giuseppe, et al.
Publicado: (2021)

Psychosocial Issues in Long-Term Survivors of Testicular Cancer
por: Schepisi, Giuseppe, et al.
Publicado: (2019)

Vitamin D status among long-term survivors of testicular cancer
por: Schepisi, Giuseppe, et al.
Publicado: (2016)

Inflammatory Biomarkers for Outcome Prediction in Patients With Metastatic Testicular Cancer
por: Bleve, Sara, et al.
Publicado: (2022)

Psoriasis on Lesions of Vitiligo: A Case Report
por: Wang, Lijuan, et al.
Publicado: (2023)

Photoallergic dermatitis and vitiligo-like lesion in a patient with metastatic breast cancer using ribociclib
por: Menteşoğlu, Dilek
Publicado: (2023)

Melphalan as a Promising Treatment for BRCA-Related Ovarian Carcinoma
por: Conteduca, Vincenza, et al.
Publicado: (2021)

Mapping architectural and transcriptional alterations in non-lesional and lesional epidermis in vitiligo
por: Singh, Archana, et al.
Publicado: (2017)

Amelanotic/hypomelanotic lentigo maligna: Dermoscopic and confocal features predicting diagnosis
por: Pizzichetta, Maria A., et al.
Publicado: (2022)

Caregiver Emotional Burden in Testicular Cancer Patients: From Patient to Caregiver Support
por: De Padova, Silvia, et al.
Publicado: (2019)

Plasma androgen receptor and serum chromogranin A in advanced prostate cancer
por: Conteduca, Vincenza, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_f1hvp75gqlvb044gejdujojt5d